Velarion · Company Intelligence
CompBrief
Fiscal year 2025

David Lennon — FY2025 total compensation $3,359,075

David Lennon is President and Chief Executive Officer of Whitehawk Therapeutics, Inc. (WHWK). The company reported total compensation of $3,359,075 for fiscal year 2025.

01

Fiscal year 2025 compensation

Salary$676,504
Bonus$390,000
Stock awards$1,318,907
Option awards$973,664
Non-equity incentive plan$0
Pension and non-qualified deferred compensation$0
All other compensation$0
Total$3,359,075

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.

Cited to the compensation disclosure Whitehawk Therapeutics, Inc. filed April 28, 2026, accession 0001193125-26-187149.

02

History — every fiscal year held

Fiscal yearRoleSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
FY2025President and Chief Executive Officer$676,504$390,000$1,318,907$973,664$0$0$0$3,359,075
FY2024President and Chief Executive Officer$654,400$0$124,800$232,868$0$0$0$1,012,068

Totals as disclosed in each year's own compensation disclosure for Whitehawk Therapeutics, Inc..

04

The other named executive officers of Whitehawk Therapeutics, Inc.

Named executive officerRoleFY2025 total
David Lennon this pagePresident and Chief Executive Officer$3,359,075
Scott GiacobelloChief Financial Officer$2,121,941
Bryan BallChief Technical Operations Officer$1,770,556

The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Whitehawk Therapeutics, Inc. compensation brief.

05

The company page

David Lennon's compensation sits inside Whitehawk Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.

The Whitehawk Therapeutics, Inc. (WHWK) compensation brief